Literature DB >> 18925303

Soft drink consumption linked with fatty liver in the absence of traditional risk factors.

Nimer Assy1, Gattas Nasser, Iad Kamayse, William Nseir, Zaza Beniashvili, Agness Djibre, Maria Grosovski.   

Abstract

BACKGROUND: Little is known about dietary habits and their relationships with liver disease in nonalcoholic fatty liver disease (NAFLD) patients, particularly in the absence of obesity, diabetes or hyperlipidemia.
OBJECTIVE: To assess the association between soft drink consumption and the presence of fatty liver in NAFLD patients who do not have classic risk factors.
METHODS: Three hundred ten patients with NAFLD diagnosed by ultrasound were assessed for 36 months in a cross-sectional manner. Thirty-one patients (10%) who had NAFLD without classic risk factors were compared with 30 healthy controls. Physical activity was assessed during the preceding week and year, and every six months for 36 months. Data on daily dietary intake of food and soft drink, and the source of added sugar were collected during two seven-day periods, at the beginning of the study, and within two weeks after the metabolic tests by using a validated food questionnaire given by a trained dietician. Insulin resistance and lipid peroxidation were assessed by homeostasis model assessment-insulin resistance index (HOMA-IRI) and malondialdehyde (MDA) levels, respectively.
RESULTS: Eighty per cent of patients (25 of 31) consumed an excessive amount of soft drink beverages (more than 50 g/day of added sugar) for 36 months, compared with 20% in healthy controls (P<0.001). Twenty per cent of patients consumed one drink per day, 40% consumed two to three drinks per day, and 40% consumed more than four drinks per day for most days during 36 months. The most common soft drinks consumed were regular Coca-Cola (40% of patients), Diet Coke (40%) and flavoured fruit juices (20%). Ultrasound findings revealed mild fatty liver in 44% of cases (n=14), moderate fatty liver in 38% (n=12), and severe fatty liver in 18% (n=5). HOMA-IRI and MDA levels were significantly higher in patients with NAFLD than in healthy controls (HOMA-IRI, 3.7 versus 1.7, P<0.001; and MDA, 420+/-300 micromol/mL versus 200+/-100 micromol/mL; P<0.001). When controlled for other factors, including dietary composition and physical activity, soft drink beverage consumption was the only independent variable that was able to predict the presence of fatty liver in 82.5% of cases with a sensitivity of 100%, a specificity of 76%, a positive predictive value of 57% and a negative predictive value of 100%.
CONCLUSION: The present study may add important insight into the role of sugar-sweetened beverage consumption as a cause of fatty liver in patients without risk factors. Patients are encouraged to change their long-standing drinking behaviour.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18925303      PMCID: PMC2661299          DOI: 10.1155/2008/810961

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  34 in total

Review 1.  Nonalcoholic fatty liver disease.

Authors:  Paul Angulo
Journal:  N Engl J Med       Date:  2002-04-18       Impact factor: 91.245

2.  High dietary fructose induces a hepatic stress response resulting in cholesterol and lipid dysregulation.

Authors:  Glen L Kelley; Geoffrey Allan; Salman Azhar
Journal:  Endocrinology       Date:  2003-10-23       Impact factor: 4.736

3.  Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women.

Authors:  Karen L Teff; Sharon S Elliott; Matthias Tschöp; Timothy J Kieffer; Daniel Rader; Mark Heiman; Raymond R Townsend; Nancy L Keim; David D'Alessio; Peter J Havel
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

4.  De novo lipogenesis during controlled overfeeding with sucrose or glucose in lean and obese women.

Authors:  R M McDevitt; S J Bott; M Harding; W A Coward; L J Bluck; A M Prentice
Journal:  Am J Clin Nutr       Date:  2001-12       Impact factor: 7.045

5.  Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy.

Authors:  Helen Vlassara; Weijing Cai; Jill Crandall; Teresia Goldberg; Robert Oberstein; Veronique Dardaine; Melpomeni Peppa; Elliot J Rayfield
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-12       Impact factor: 11.205

6.  Fatty infiltration of liver in hyperlipidemic patients.

Authors:  N Assy; K Kaita; D Mymin; C Levy; B Rosser; G Minuk
Journal:  Dig Dis Sci       Date:  2000-10       Impact factor: 3.199

7.  Response of liver antioxidant system to taurine in rats fed high fructose diet.

Authors:  A T Anitha Nandhini; S D Balakrishnan; C V Anuradha
Journal:  Indian J Exp Biol       Date:  2002-09       Impact factor: 0.818

Review 8.  Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation.

Authors:  Anne Burke; Michael R Lucey
Journal:  Am J Transplant       Date:  2004-05       Impact factor: 8.086

9.  The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation.

Authors:  Masahide Hamaguchi; Takao Kojima; Yoshito Itoh; Yuichi Harano; Kota Fujii; Tomoaki Nakajima; Takahiro Kato; Noriyuki Takeda; Junichi Okuda; Kazunori Ida; Yutaka Kawahito; Toshikazu Yoshikawa; Takeshi Okanoue
Journal:  Am J Gastroenterol       Date:  2007-09-25       Impact factor: 10.864

10.  Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse.

Authors:  Susanna M Hofmann; Heng-Jiang Dong; Zhu Li; Weijing Cai; Jennifer Altomonte; Swan N Thung; Feng Zeng; Edward A Fisher; Helen Vlassara
Journal:  Diabetes       Date:  2002-07       Impact factor: 9.461

View more
  103 in total

1.  Cumulative soft drink consumption is associated with insulin resistance in Mexican adults.

Authors:  Berenice Rivera-Paredez; Leticia Torres-Ibarra; Romina González-Morales; Tonatiuh Barrientos-Gutiérrez; Rubí Hernández-López; Paula Ramírez; Leith León-Maldonado; Rafael Velázquez-Cruz; Edgar Denova-Gutiérrez; Jorge Salmerón
Journal:  Am J Clin Nutr       Date:  2020-09-01       Impact factor: 7.045

Review 2.  Fructose-mediated effects on gene expression and epigenetic mechanisms associated with NAFLD pathogenesis.

Authors:  Johanna K DiStefano
Journal:  Cell Mol Life Sci       Date:  2020-06       Impact factor: 9.261

3.  Beverage consumption in Brazil: results from the first National Dietary Survey.

Authors:  Rosangela A Pereira; Amanda M Souza; Kiyah J Duffey; Rosely Sichieri; Barry M Popkin
Journal:  Public Health Nutr       Date:  2014-08-27       Impact factor: 4.022

Review 4.  Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials.

Authors:  G Musso; M Cassader; F Rosina; R Gambino
Journal:  Diabetologia       Date:  2012-01-27       Impact factor: 10.122

Review 5.  Genome-based nutrition: an intervention strategy for the prevention and treatment of obesity and nonalcoholic steatohepatitis.

Authors:  Sonia Roman; Claudia Ojeda-Granados; Omar Ramos-Lopez; Arturo Panduro
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

6.  Sugar-sweetened beverage consumption and the progression of chronic kidney disease in the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Andrew S Bomback; Ronit Katz; Ka He; David A Shoham; Gregory L Burke; Philip J Klemmer
Journal:  Am J Clin Nutr       Date:  2009-09-09       Impact factor: 7.045

7.  Metabolic responses to prolonged consumption of glucose- and fructose-sweetened beverages are not associated with postprandial or 24-h glucose and insulin excursions.

Authors:  Kimber L Stanhope; Steven C Griffen; Andrew A Bremer; Roel G Vink; Ernst J Schaefer; Katsuyuki Nakajima; Jean-Marc Schwarz; Carine Beysen; Lars Berglund; Nancy L Keim; Peter J Havel
Journal:  Am J Clin Nutr       Date:  2011-05-25       Impact factor: 7.045

Review 8.  Dietary habits and behaviors associated with nonalcoholic fatty liver disease.

Authors:  Kenichiro Yasutake; Motoyuki Kohjima; Kazuhiro Kotoh; Manabu Nakashima; Makoto Nakamuta; Munechika Enjoji
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

Review 9.  Implications of diet on nonalcoholic fatty liver disease.

Authors:  Shelby Sullivan
Journal:  Curr Opin Gastroenterol       Date:  2010-03       Impact factor: 3.287

10.  Beneficial effect of a weight-stable, low-fat/low-saturated fat/low-glycaemic index diet to reduce liver fat in older subjects.

Authors:  Kristina M Utzschneider; Jennifer L Bayer-Carter; Matthew D Arbuckle; Jaime M Tidwell; Todd L Richards; Suzanne Craft
Journal:  Br J Nutr       Date:  2012-07-31       Impact factor: 3.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.